153 related articles for article (PubMed ID: 35244521)
1. Injection of YiQiFuMai powder protects against heart failure via inhibiting p38 and ERK1/2 MAPKs activation.
Nie Y; Zhang Y; Li Z; Wan M; Li D
Pharm Biol; 2022 Dec; 60(1):570-578. PubMed ID: 35244521
[TBL] [Abstract][Full Text] [Related]
2. YiQiFuMai Powder Injection attenuates coronary artery ligation-induced myocardial remodeling and heart failure through modulating MAPKs signaling pathway.
Pang LZ; Ju AC; Zheng XJ; Li F; Song YF; Zhao Y; Gu YF; Chen FL; Liu CH; Qi J; Gao Z; Kou JP; Yu BY
J Ethnopharmacol; 2017 Apr; 202():67-77. PubMed ID: 28237302
[TBL] [Abstract][Full Text] [Related]
3. YiQiFuMai powder injection ameliorates chronic heart failure through cross-talk between adipose tissue and cardiomyocytes via up-regulation of circulating adipokine omentin.
Li F; Pang LZ; Zhang L; Zhang Y; Zhang YY; Yu BY; Kou JP
Biomed Pharmacother; 2019 Nov; 119():109418. PubMed ID: 31505423
[TBL] [Abstract][Full Text] [Related]
4. Xinmailong mitigated epirubicin-induced cardiotoxicity via inhibiting autophagy.
Li H; Mao Y; Zhang Q; Han Q; Man Z; Zhang J; Wang X; Hu R; Zhang X; Irwin DM; Niu G; Tan H
J Ethnopharmacol; 2016 Nov; 192():459-470. PubMed ID: 27586823
[TBL] [Abstract][Full Text] [Related]
5. Cardioprotective effects of the YiQiFuMai injection and isolated compounds on attenuating chronic heart failure via NF-κB inactivation and cytokine suppression.
Xing L; Jiang M; Dong L; Gao J; Hou Y; Bai G; Luo G
J Ethnopharmacol; 2013 Jun; 148(1):239-45. PubMed ID: 23619019
[TBL] [Abstract][Full Text] [Related]
6. YiQiFuMai Powder Injection Attenuates Coronary Artery Ligation-Induced Heart Failure Through Improving Mitochondrial Function via Regulating ROS Generation and CaMKII Signaling Pathways.
Zhang Y; Zhang L; Zhang Y; Fan X; Yang W; Yu B; Kou J; Li F
Front Pharmacol; 2019; 10():381. PubMed ID: 31031629
[TBL] [Abstract][Full Text] [Related]
7. Optimized new Shengmai powder inhibits myocardial fibrosis in heart failure by regulating the rat sarcoma/rapidly accelerated fibrosarcoma/mitogen-activated protein kinase kinase/extracellular regulated protein kinases signaling pathway.
Zeyu Z; Zhuangzhuang J; Yuwei S; Xuan Z; Ci W; Shuai W; Peipei Z; Qiuan R; Xianliang W; Jingyuan M
J Tradit Chin Med; 2024 Jun; 44(3):448-457. PubMed ID: 38767628
[TBL] [Abstract][Full Text] [Related]
8. YiQiFuMai Powder Injection Attenuates Ischemia/Reperfusion-Induced Myocardial Apoptosis Through AMPK Activation.
Li F; Zheng X; Fan X; Zhai K; Tan Y; Kou J; Yu B
Rejuvenation Res; 2016 Dec; 19(6):495-508. PubMed ID: 27072567
[TBL] [Abstract][Full Text] [Related]
9. YQFM alleviated cardiac hypertrophy by apoptosis inhibition and autophagy regulation via PI
Wan M; Yin K; Yuan J; Ma S; Xu Q; Li D; Gao H; Gou X
J Ethnopharmacol; 2022 Mar; 285():114835. PubMed ID: 34798161
[TBL] [Abstract][Full Text] [Related]
10. Qiliqiangxin improves cardiac function and attenuates cardiac remodeling in rats with experimental myocardial infarction.
Wang J; Zhou J; Ding X; Zhu L; Jiang K; Fu M; Wang S; Hu K; Ge J
Int J Clin Exp Pathol; 2015; 8(6):6596-606. PubMed ID: 26261541
[TBL] [Abstract][Full Text] [Related]
11. YiQiFuMai Lyophilized Injection ameliorates tPA-induced hemorrhagic transformation by inhibiting cytoskeletal rearrangement associated with ROCK1 and NF-κB signaling pathways.
Pan XW; Wang MJ; Gong SS; Sun MH; Wang Y; Zhang YY; Li F; Yu BY; Kou JP
J Ethnopharmacol; 2020 Nov; 262():113161. PubMed ID: 32730882
[TBL] [Abstract][Full Text] [Related]
12. YiQiFuMai Powder Injection ameliorates the oxygen-glucose deprivation-induced brain microvascular endothelial barrier dysfunction associated with the NF-κB and ROCK1/MLC signaling pathways.
Cao GS; Chen HL; Zhang YY; Li F; Liu CH; Xiang X; Qi J; Chai CZ; Kou JP; Yu BY
J Ethnopharmacol; 2016 May; 183():18-28. PubMed ID: 26915982
[TBL] [Abstract][Full Text] [Related]
13. Exploring the protective effects of PNS on acute myocardial ischaemia-induced heart failure by Transcriptome analysis.
Chen X; Ma L; Shao M; Wang Q; Jiang Q; Guo D; Zhang P; Yang R; Li C; Wang Y; Wang W
J Ethnopharmacol; 2021 May; 271():113823. PubMed ID: 33472092
[TBL] [Abstract][Full Text] [Related]
14. Analysis of microRNA Expression Profiles Induced by Yiqifumai Injection in Rats with Chronic Heart Failure.
Zhao Y; Li Y; Tong L; Liang X; Zhang H; Li L; Fan G; Wang Y
Front Physiol; 2018; 9():48. PubMed ID: 29467665
[No Abstract] [Full Text] [Related]
15. YiQiFuMai Powder Injection Protects against Ischemic Stroke via Inhibiting Neuronal Apoptosis and PKC
Xu Y; Wang Y; Wang G; Ye X; Zhang J; Cao G; Zhao Y; Gao Z; Zhang Y; Yu B; Kou J
Oxid Med Cell Longev; 2017; 2017():1832093. PubMed ID: 29435096
[TBL] [Abstract][Full Text] [Related]
16. p38 mitogen-activated protein kinase inhibition decreases TNFalpha secretion and protects against left ventricular remodeling in rats with myocardial ischemia.
Yin H; Zhang J; Lin H; Wang R; Qiao Y; Wang B; Liu F
Inflammation; 2008 Apr; 31(2):65-73. PubMed ID: 17943427
[TBL] [Abstract][Full Text] [Related]
17. Shenfu Formula reduces cardiomyocyte apoptosis in heart failure rats by regulating microRNAs.
Yan X; Wu H; Ren J; Liu Y; Wang S; Yang J; Qin S; Wu D
J Ethnopharmacol; 2018 Dec; 227():105-112. PubMed ID: 29746994
[TBL] [Abstract][Full Text] [Related]
18. YiQiFuMai powder injection ameliorates blood-brain barrier dysfunction and brain edema after focal cerebral ischemia-reperfusion injury in mice.
Cao G; Ye X; Xu Y; Yin M; Chen H; Kou J; Yu B
Drug Des Devel Ther; 2016; 10():315-25. PubMed ID: 26834461
[TBL] [Abstract][Full Text] [Related]
19. Baoyuan decoction ameliorates apoptosis via AT1-CARP signaling pathway in H9C2 cells and heart failure post-acute myocardial infarction rats.
Wang X; Meng H; Wang Q; Shao M; Lu W; Chen X; Jiang Y; Li C; Wang Y; Tu P
J Ethnopharmacol; 2020 Apr; 252():112536. PubMed ID: 31931161
[TBL] [Abstract][Full Text] [Related]
20. Cyclovirobuxinum D alleviates cardiac hypertrophy in hyperthyroid rats by preventing apoptosis of cardiac cells and inhibiting the p38 mitogen-activated protein kinase signaling pathway.
Wu JB; Zhou Y; Liang CL; Zhang XJ; Lai JM; Ye SF; Ouyang H; Lin J; Zhou JY
Chin J Integr Med; 2017 Oct; 23(10):770-778. PubMed ID: 27048408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
